196 related articles for article (PubMed ID: 25842366)
1. Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.
Kawaguchi M; Kanemaru A; Sawaguchi A; Yamamoto K; Baba T; Lin CY; Johnson MD; Fukushima T; Kataoka H
Am J Pathol; 2015 Jun; 185(6):1610-23. PubMed ID: 25842366
[TBL] [Abstract][Full Text] [Related]
2. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
[TBL] [Abstract][Full Text] [Related]
3. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
4. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in Apc
Kawaguchi M; Yamamoto K; Kataoka H; Izumi A; Yamashita F; Kiwaki T; Nishida T; Camerer E; Fukushima T
Cancer Sci; 2020 Apr; 111(4):1193-1202. PubMed ID: 31997435
[TBL] [Abstract][Full Text] [Related]
6. Role of matriptase and proteinase-activated receptor-2 in nonmelanoma skin cancer.
Bocheva G; Rattenholl A; Kempkes C; Goerge T; Lin CY; D'Andrea MR; Ständer S; Steinhoff M
J Invest Dermatol; 2009 Jul; 129(7):1816-23. PubMed ID: 19242518
[TBL] [Abstract][Full Text] [Related]
7. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/
Yamamoto K; Kawaguchi M; Shimomura T; Izumi A; Konari K; Honda A; Lin CY; Johnson MD; Yamashita Y; Fukushima T; Kataoka H
Oncotarget; 2018 Feb; 9(14):11691-11706. PubMed ID: 29545930
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.
Kawaguchi M; Takeda N; Hoshiko S; Yorita K; Baba T; Sawaguchi A; Nezu Y; Yoshikawa T; Fukushima T; Kataoka H
Am J Pathol; 2011 Oct; 179(4):1815-26. PubMed ID: 21840293
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation.
Chen YW; Wang JK; Chou FP; Chen CY; Rorke EA; Chen LM; Chai KX; Eckert RL; Johnson MD; Lin CY
J Biol Chem; 2010 Oct; 285(41):31755-62. PubMed ID: 20696767
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.
Hoshiko S; Kawaguchi M; Fukushima T; Haruyama Y; Yorita K; Tanaka H; Seiki M; Inatsu H; Kitamura K; Kataoka H
Cancer Res; 2013 Apr; 73(8):2659-70. PubMed ID: 23447577
[TBL] [Abstract][Full Text] [Related]
14. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
15. Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.
Seitz I; Hess S; Schulz H; Eckl R; Busch G; Montens HP; Brandl R; Seidl S; Schömig A; Ott I
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):769-75. PubMed ID: 17255532
[TBL] [Abstract][Full Text] [Related]
16. Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2.
Shiao F; Liu LO; Huang N; Lai YJ; Barndt RJ; Tseng CC; Wang JK; Jia B; Johnson MD; Lin CY
PLoS One; 2017; 12(1):e0170944. PubMed ID: 28125689
[TBL] [Abstract][Full Text] [Related]
17. HAI-1 is required for the novel role of FGFBP1 in maintenance of cell morphology and F-actin rearrangement in human keratinocytes.
Lu DD; Huang N; Li SA; Fang JR; Lai CH; Wang JK; Chan KS; Johnson MD; Lin CY
Hum Cell; 2023 Jul; 36(4):1403-1415. PubMed ID: 37076641
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
[TBL] [Abstract][Full Text] [Related]
19. Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.
Barndt RB; Lee MJ; Huang N; Lu DD; Lee SC; Du PW; Chang CC; Tsai PB; Huang YK; Chang HM; Wang JK; Lai CH; Johnson MD; Lin CY
Hum Mol Genet; 2021 Sep; 30(19):1833-1850. PubMed ID: 34089062
[TBL] [Abstract][Full Text] [Related]
20. Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.
Szabo R; Kosa P; List K; Bugge TH
Am J Pathol; 2009 Jun; 174(6):2015-22. PubMed ID: 19389929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
